[JSNM]Oral

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » 一般演題

Oral 02:Chemistry 2

Thu. Nov 7, 2024 9:35 AM - 10:35 AM Room 3 (5F 511+512, Conference Center, PACIFICO Yokohama)

座長：加川信也（滋賀県立総合病院臨床研究センター）、清野泰（福井大学高エネルギー医学研究センター）

+Add all to schedule

[1-MO02-1] Synthesis and evaluation of¹⁸F-PET ligands for monoacylglycerol lipase in brain

Wakana Mori¹、Nobuki Nengaki^1,2、Tomoteru Yamasaki¹、Masayuki Fujinaga¹、Ming-Rong Zhang¹ (1.Department of Advanced Nuclear Medicine Sciences, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology., Chiba, Japan、2.SHI Accelerator Service Ltd., Tokyo, Japan)

[1-MO02-2] Development of PET probes based on 1,4-diazepane scaffold targeting orexin 1 receptors

Hiroyuki Watanabe、Yui Ishizaka、Masahiro Ono (Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan)

[1-MO02-3] PET Probe Development for Aldosterone-Producing Adenomas: SAR and Comparative Study

Toko Otaka^1,2、Yuki Shimizu^1,3、Yuto Yamazaki⁴、Yuta Tezuka⁵、Gesshu Takao^1,2、Kei Omata⁵、Yoshikiyo Ono⁵、Yoshitaka Toyama⁶、Ryuichi Harada¹、Tomohiro Kaneta⁶、Shozo Furumoto^1,2 (1.Research center for Accelerator and Radioisotope Science, Tohoku University, Sendai, Japan、2.Faculty of Pharmaceutical Sciences, Tohoku University, Sendai, Japan、3.Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan、4.Department of Pathology, Tohoku University Hospital, Sendai, Japan、5.Department of Diabetes, Metabolism and Endocrinology, Tohoku University Hospital, Sendai, Japan、6.Department of Diagnostic Radiology, Tohoku University Hospital, Sendai, Japan)

[1-MO02-4] Development of in vivo molecular imaging probe for activated p38alpha

Mikiya Futatsugi¹、Anna Miyazaki¹、Yasukazu Kanai²、Naoya Kondo¹、Takashi Temma¹ (1.Graduate School of Pharmaceutical Sciences, Osaka Medical and Pharmaceutical University, Osaka, Japan、2.Kansai BNCT Medical Center, Educational Foundation of Osaka Medical and Pharmaceutical University, Osaka, Japan)

[1-MO02-5] Development of a brain PET imaging ligand targeting glucose transporter 1

Takayuki Sakai^1,2、Hiroshi Ikenuma²、Takashi Yamada^2,3、Aya Ogata^2,4、Masanori Ishise²、Mari Tada⁵、Akiyoshi Kakita⁵、Takashi Kato²、Kengo Ito²、Shozo Furumoto¹、Yasuyuki Kimura² (1.Recearch Center for Accelertor and Radioisotope Science, Tohoku University, Miyagi, Japan、2.National Center for Geriatrics and Gerontology, Obu, Aichi, Japan、3.Nagoya University of Economics, Inuyama, aichi, Japan、4.Gifu University of Medical Science, Kani, Gifu, Japan、5.Niigata University)

[1-MO02-6] Radiosynthesis and assessment of [¹⁸F]Fluoroacetate derivatives

Shinya Kagawa¹、Chio Okuyama¹、Hiroshi Mizuma^2,3、Hirotaka Onoe⁴、Ryuichi Nishii^1,5、Tatsuya Higashi^1,3 (1.Division of PET Imaging, Clinical Research Center, Shiga General Hospital, Shiga, Japan、2.Osaka Metropolitan University Graduate School of Medicine, Ooska, Japan、3.Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan、4.Kobe Gakuin University Faculty of Pharmaceutical Sciences, Laboratory of Neuropsychopharmacology, Kobe, Japan、5.Biomedical Imaging Sciences, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan)